ARCHIVES

FDA Delays Decision On Avastin Approval For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Center To Get Recommended Funding, Restoration of 1990-91 Cuts, NCI Tells Directors

July 24, 1992

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

April 21, 1995

Duke Officials Decline To Provide Details Of Probe

July 23, 2010